You are here

Treatments

Cognitive behavioral therapy reduces severe fatigue in long-COVID patients --Dutch study

Tue, 2023-05-09 19:25 — mike kraft

Cognitive behavioral therapy reduces severe fatigue in long-COVID patients Cognitive behavioral therapy lessens fatigue and improves concentration among long-COVID patients. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Cognitive behavioral therapy reduces severe fatigue in long-COVID patients --Dutch study
Log in or register to post comments

China's CanSinoBIO's inhaled COVID booster reported stronger against BA.1 Omicron subvariant than Sinovac shot

Tue, 2023-05-09 10:21 — mike kraft

CanSinoBIO's inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but the antibody level dropped in months, clinical trial data showed. Reuters R

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Opinion: The Covid-19 emergency is ending. It’s time for the patient to leave the hospital

Tue, 2023-05-09 10:06 — mike kraft

Dr. Sanjay Gupta: The Covid-19 emergency is ending. It's time for the patient to leave the hospital | CNN After more than three very long years, it's finally happening: The Covid-19 pandemic is ending, at least in the formal sense, both in this country and abroad. This moment is not being marked with parades or big parties but rather with the flourishes of two administrative pens. On Friday, the World Health Organization announced that Covid-19 no longer constitutes a Public Health Emergency of International Concern, and this Thursday, the United States is set to end its own public health emergency declaration. Dr.

Country / Region Tags:

General Topic Tags:

Medical Personnel

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Opinion: The Covid-19 emergency is ending. It’s time for the patient to leave the hospital
Log in or register to post comments

Analysis: Research into treating long COVID is stuck

Mon, 2023-05-08 09:42 — mike kraft

Long COVID Treatment Research Is Stuck in a Frustrating Catch-22 Patients are feeling abandoned, for good reason. Liz Highleyman Slate Magazine

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Analysis: Research into treating long COVID is stuck
Log in or register to post comments

Analysis: Failures in achieving COVID-19 vaccine equity

Fri, 2023-05-05 17:11 — mike kraft

Cascading failures in COVID-19 vaccine equity Ethical analysis should encompass upstream decisions and their downstream consequences Science

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Analysis: Failures in achieving COVID-19 vaccine equity
Log in or register to post comments

WHO releases strategy paper on COVID disease management and long-term disease prevention

Thu, 2023-05-04 10:55 — mike kraft

From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic The updated two-year strategy builds on the objectives of the 2022 SPRP and supports countries as they are working to transition their critical emergency response activities to longer-term sustained COVID-19 disease prevention, control and management.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Personnel

Social behavior

Problem, Solution, SitRep, or ?:

Read more about WHO releases strategy paper on COVID disease management and long-term disease prevention
Log in or register to post comments

U.S. FDA approves first RSV vaccine, a long-sought scientific achievement

Wed, 2023-05-03 13:24 — mike kraft

FDA approves first RSV vaccine, a long-sought scientific achievement The FDA has approved the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making. Helen Branswell STAT

... The product, GSK’s Arexvy, was approved for adults ages 60 and older.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA approves first RSV vaccine, a long-sought scientific achievement
Log in or register to post comments

After COVID and drug shortages, EU revamps drug laws

Thu, 2023-04-27 10:09 — mike kraft

Explainer: After COVID and drug shortages, EU revamps drug laws The EU is revamping laws governing the 136 billion euro ($148 billion) pharmaceuticals industry aimed at reviving investment and boosting access to affordable drugs at a time when health budgets have been drained by the costs of treating COVID-19. Maggie Fick Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about After COVID and drug shortages, EU revamps drug laws
Log in or register to post comments

Increased physical activity associated with lower risk of severe COVID-19 --study

Thu, 2023-04-27 08:47 — mike kraft

Increased physical activity associated with lower risk of severe COVID-19 CIDRAP

A South Korean study shows a complex relationship between moderate to vigorous physical activity (MVPA) and COVID-19, with a regular exercise habit linked to COVID-19 infection early in the pandemic but also associated with a significantly lower risk of developing severe symptoms. The study was published yesterday in JAMA Network Open.

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Increased physical activity associated with lower risk of severe COVID-19 --study
Log in or register to post comments

SAB Biotherapeutics Reports Positive Results from COVID Drug SAB-185

Wed, 2023-04-26 10:27 — mike kraft

SAB Biotherapeutics Sees Positive Results from COVID Drug SAB-185 By Exec Edge Editorial Staff SAB Biotherapeutics (Nasdaq: SABS) said it saw positive results from a Phase 3 clinical trial that assessed its Covid-19 drug, SAB-185, in non-hospitalized people who were at high-risk for severe outcomes. SAB-185 demonstrated benefit in sustained symptom resolution in study participants with Covid-19 caused by Omicron as compared to participants […] Yahoo Finance

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about SAB Biotherapeutics Reports Positive Results from COVID Drug SAB-185
Log in or register to post comments

Pages

Page loaded in 0.667 seconds.